New target explored for psychiatric drug development

In a surprising discovery, neuroscientists, led by a team from Washington University School of Medicine in St. Louis, have found that a molecule that is a breakdown product of cholesterol in the brain may be a target for developing new drugs to treat schizophrenia and other mental illnesses.

School of Medicine celebrates launch of Taylor Family Institute

The Department of Psychiatry is hosting a celebration Tuesday, Oct. 1, to mark the official launch of the Taylor Family Institute for Innovative Psychiatric Research. The institute, dedicated to advancing the science underlying the diagnosis and treatment of psychiatric illnesses, was created with a $20 million gift from Andy and Barbara Taylor and the Crawford Taylor Foundation. Pictured are institute investigators.